Useful links
Unit of study_
PHAR5723: Immunology and Cancer
2025 unit information
This unit of study integrates pharmaceutical sciences and pharmacy-practice content relating to the treatment of oncological and immunological conditions. The unit will cover the pharmaceutical sciences that underpin drug therapies used in managing these conditions; the physiology, epidemiology, pathophysiology and clinical features of the conditions; and practice-related aspects in professional pharmacy services including disease state management, familiarisation with computerised drug information databases and vaccination training. Knowledge gained is applied in case-based scenarios, workshops, and role plays, where students have the opportunity to assimilate the learnt information and apply them to optimise the pharmacological and nonpharmacological management of patients with these conditions. Interprofessional communication and the application of knowledge through clinical interventions and/or medication management review will also be explored.
Unit details and rules
Managing faculty or University school:
Medicine and Health
| Study level | Postgraduate |
|---|---|
| Academic unit | Pharmacy |
| Credit points | 6 |
|
Prerequisites:
?
|
PHAR5911 and PHAR5712 and PHAR5713 and PHAR5714 and PHAR5715 and PHAR5716 and PHAR5717 and PHAR5718 |
|---|---|
|
Corequisites:
?
|
PHAR5721 and PHAR5722 |
| Prohibitions:
?
|
None |
| Assumed knowledge:
?
|
None |
At the completion of this unit, you should be able to:
- LO1. Demonstrate an understanding of the epidemiology and pathophysiology associated with immunological disorders and cancer
- LO2. Identify the most appropriate evidence-based treatments and the appropriate advice and counselling to patients with immunological disorders and cancer
- LO3. Demonstrate an understanding of the chemistry and pharmacology that forms the basis of structure-activity relationships, drug-drug interactions, and drug design of medicines used for immunological disorders and cancer
- LO4. Identify and manage medication-related adverse events and provide appropriate advice/counselling to patients with immunological disorders and cancer or other health care professionals
- LO5. Communicate effectively and ethically with patients, their families, and other health care professionals about the optimal management of immunological disorders and cancer
- LO6. Identify and utilise appropriate resources that are used to form the basis of decisions on which medicines and services are recommended to patients with immunological disorders and cancer and other health care professionals
- LO7. Critically examine scientific evidence, both quantitative and qualitative, in order to arrive at evidence-based conclusions
- LO8. Work effectively and cooperatively as a member of a learning team
Unit availability
This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.
The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.
| Session | MoA ? | Location | Outline ? |
|---|---|---|---|
|
Semester 1 2025
|
Normal day | Camperdown/Darlington, Sydney |
Outline unavailable
|
Find your current year census dates
Modes of attendance (MoA)
This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.
